論文 - 詳細
| RRC ID | 19165 |
|---|---|
| 著者 | Yukawa H, Noguchi H, Nakase I, Miyamoto Y, Oishi K, Hamajima N, Futaki S, Hayashi S. |
| タイトル | Transduction of cell-penetrating peptides into induced pluripotent stem cells. |
| ジャーナル | Cell Transplant |
| Abstract |
Induced pluripotent stem (iPS) cells have recently been generated by Yamanaka's group, and then followed by others. iPS cells are expected to have clinical applications including an important role in regenerative medicine. This study focused on the cell-penetrating peptides (CPPs) for differentiation or functional application of iPS cells, because several transduction domains can deliver a large size-independent variety of molecules into cells. Two CPPs, Texas Red-R8 and Rhodamine-TAT, were generated as representative CPPs and these CPPs were tested to determine their ability to penetrate the membrane of iPS cells. Both CPPs were transduced in iPS cells through macropinocytosis classified in endocytosis within 2 h in a manner consistent with many other cells, and no cytotoxicity and influence on their undifferentiated state was observed. In conclusion, CPPs can be utilized for their differentiation or functional application in iPS cells. |
| 巻・号 | 19(6) |
| ページ | 901-9 |
| 公開日 | 2010-1-1 |
| DOI | 10.3727/096368910X509031 |
| PII | ct2275yukawa |
| PMID | 20587149 |
| MeSH | Animals Cell-Penetrating Peptides / metabolism* Drug Delivery Systems / methods* Extracellular Space / metabolism Induced Pluripotent Stem Cells / cytology Induced Pluripotent Stem Cells / metabolism* Kinetics Membrane Microdomains / metabolism Mice Pinocytosis |
| IF | 3.341 |
| 引用数 | 16 |
| WOS 分野 | MEDICINE, RESEARCH & EXPERIMENTAL TRANSPLANTATION CELL & TISSUE ENGINEERING |
| オルトメトリクス指標 |
オルトメトリクス指標項目
|
| 最多言及媒体 | Patent(IFI CLAIMS) |
| 各媒体での言及数の合計 | 2 |
| 過去6か月間でのオルトメトリクス指標の変動値 | 0.0 |
| リソース情報 | |
| ヒト・動物細胞 | iPS-MEF-Ng-20D-17(APS0001) |